...
首页> 外文期刊>Cardiovascular revascularization medicine: including molecular interventions >In-Stent Restenosis, the Achilles' Heel of Percutaneous Coronary Intervention: The Predictive Role of High-Sensitivity C-Reactive Protein
【24h】

In-Stent Restenosis, the Achilles' Heel of Percutaneous Coronary Intervention: The Predictive Role of High-Sensitivity C-Reactive Protein

机译:支架再狭窄,经皮冠状动脉介入的阿基尔脚跟:高敏感性C反应蛋白的预测作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Percutaneous coronary intervention, including intracoronary stenting represents a major revolutionary game-changer in the field of interven-tional cardiology. Intracoronary stents have been shown to increase procedural safety and reduce the number of cardiovascular events compared to balloon angioplasty. However, it remains fraught with the perils of in-stent restenosis [1 ]. In-stent restenosis (ISR) has always been the Achilles' heel of percutaneous coronary intervention (PCI). It is defined as the degree of lumen diameter reduction following PCI.
机译:经皮冠状动脉干预,包括颅内支架代表了干预心脏病学领域的主要革命性比赛。 与气囊血管成形术相比,已显示颅内支架增加程序安全性并减少心血管事件的数量。 然而,它仍然充满了支架内再狭窄的危险[1]。 支架再狭窄(ISR)一直是经皮冠状动脉干预(PCI)的Achilles的脚跟。 它定义为PCI后的腔直径减少程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号